Current Rheumatology Reports, 10 (2), 110
Discontinued formulations Efpeglenatide and taspoglutide Efpeglenatide and taspoglutide were once-promising, long-acting GLP-1 receptor agonists developed for the treatment of T2DM, both designed for once-weekly administration
Tang WH, Wang Z, Kennedy DJ, Wu Y, Buffa JA, Agatisa-Boyle B, Li XS, Levison BS, Hazen SL
TIER 1 (120mg total) $250 total for 8 week supply Monthly cost breakdown: $125 Custom Oral GLP-1 Treatment Plans Custom oral GLP-1 treatment plans are designed for those seeking a non-injectable option for weight management and metabolic support
Everything You Need to Know Sermorelin is a peptide that helps your body naturally produce more growth hormone